These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 11784471)

  • 1. Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.
    Sutton AJ; Edmunds WJ; Gill ON
    BMC Public Health; 2006 Jun; 6():170. PubMed ID: 16803622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users.
    Gjersing L; Bretteville-Jensen AL
    BMC Public Health; 2014 May; 14():440. PubMed ID: 24886464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.
    Hope V; Kimber J; Vickerman P; Hickman M; Ncube F
    BMC Infect Dis; 2008 Sep; 8():120. PubMed ID: 18801177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute infections in intravenous drug users.
    Lavender TW; McCarron B
    Clin Med (Lond); 2013 Oct; 13(5):511-3. PubMed ID: 24115713
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetanus in injecting drug users.
    Beeching NJ; Crowcroft NS
    BMJ; 2005 Jan; 330(7485):208-9. PubMed ID: 15677636
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.
    Seifert LL; Heinzow H; Kabar I; Christensen S; Hüsing A; Schmidt HH
    Am J Case Rep; 2016 Aug; 17():605-10. PubMed ID: 27554644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.
    Gelberg L; Robertson MJ; Arangua L; Leake BD; Sumner G; Moe A; Andersen RM; Morgenstern H; Nyamathi A
    Public Health Rep; 2012; 127(4):407-21. PubMed ID: 22753984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of delivering hepatitis B vaccine to injection drug users.
    Hu Y; Grau LE; Scott G; Seal KH; Marshall PA; Singer M; Heimer R
    Am J Prev Med; 2008 Jul; 35(1):25-32. PubMed ID: 18541174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.
    Stoové MA; Fry CL; Lintzeris N
    Harm Reduct J; 2008 Apr; 5():12. PubMed ID: 18433470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
    Novick DM; Kreek MJ
    Addiction; 2008 Jun; 103(6):905-18. PubMed ID: 18422827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
    Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
    Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
    Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
    Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of the correct strategy for preventing the spread of HCV infection.
    Montella M; Crispo A; Wynn-Bellezza J
    Gut; 2004 May; 53(5):771-2. PubMed ID: 15082602
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment.
    Cook PA; McVeigh J; Syed Q; Mutton K; Bellis MA
    Addiction; 2001 Dec; 96(12):1787-97. PubMed ID: 11784471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatitis C virus in special populations: patient and treatment considerations.
    Gish RG; Afdhal NH; Dieterich DT; Reddy KR
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):311-8. PubMed ID: 15822034
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.